Dr. Steven K. Grinspoon
Harvard Medical School and leads the Program in Nutritional Metabolism at Massachusetts General Hospital
Biography & Research Background
Steven K. Grinspoon, MD, is Professor of research compound at Harvard Medical School and leads the Program in Nutritional Metabolism at Massachusetts General Hospital. He served as the lead US investigator for the Egrifta clinical trials and his research spans visceral adipose tissue, cardiovascular risk, and NAFLD in HIV-infected study subjects. He is a named inventor on the NAFLD/NASH patent for Tesamorelin. Steven K. Grinspoon is being referenced as one of the leading scientists involved in the research and development of Tesamorelin. In no way is this doctor/scientist endorsing or advocating the purchase, sale, or use of this product for any reason. There is no affiliation or relationship, implied or otherwise, between Pure US Peptide and this doctor.
External Profiles
Authored Research Profiles (1)
Dr. Steven K. Grinspoon is referenced as a leading researcher in the following peptide research profiles on Pure U.S. Peptides:
Dr. Steven K. Grinspoon is being referenced as one of the leading scientists involved in the research and development of the peptides listed above. In no way is this doctor/scientist endorsing or advocating the purchase, sale, or use of any product for any reason. There is no affiliation or relationship, implied or otherwise, between Pure U.S. Peptides and this researcher. The purpose of citing the researcher is to acknowledge, recognize, and credit the exhaustive research and development efforts conducted by the scientists studying these peptides.